David Huang, MD, PhD, FARVO, of the Casey Eye Institute at Oregon Health & Science University has been named the second recipient of the Dr. David L. Epstein Award. This annual award carrying a $100,000 prize, recognizes a senior investigator in glaucoma who has a strong record of mentoring clinician-scientists to independent research in academic careers.
Huang is the Peterson Professor of Ophthalmology and a professor of biomedical engineering at the Oregon Health and Science University. He is most well-known for his role as co-inventor of optical coherence tomography (OCT), among numerous other scientific achievements. He has 16 issued patents and 14 pending patents, over 170 peer-reviewed articles and has been the principal investigator of five NIH research grants totaling over $20 million. He is also the co-recipient of the 2012 António Champalimaud Vision Award.
Huang will be presented with the Epstein Award at the General Business Meeting at the ARVO 2017 Annual Meeting on Tuesday, May 9 at 10:15am.
Dr. David L. Epstein, for whom the award is named, is widely considered to be one of the most influential leaders in the world of glaucoma and glaucoma research over the past 30 years. When Dr. Epstein passed away in 2014, his family created the award in his name to perpetuate and honor his commitment to the scientific understanding and cure of glaucoma through the support of promising clinician-scientists in exceptional research environments. The first award was given in 2016.